Atrial Fibrillation: Flecainide vs. Amiodarone

We are studying whether flecainide is more effective and safe than amiodarone for treating paroxysmal atrial fibrillation in patients with coronary disease. This trial aims to see if it can restore normal heart rhythm faster and reduce hospital visits.

>2 years Confirmation phase (III)No Placebo Standard Medicines InjectionCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Angoron

Flecardia

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Amiodarone Hydrochloride

Amiodarone hydrochloride is a substance used to help control serious abnormal heart rhythms.

Flecainide

Flecainide is a substance used to treat certain irregular heartbeats by stabilizing the heart's electrical signals.

Flecainide Acetate

Flecainide acetate is a substance that helps restore normal heart rhythm by stabilizing electrical activity to treat certain irregular heartbeats.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Almarytm

Amarhyton

Amiodar

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Hippokration Hospital

First Cardiology Department

Athens, Greece

Kat Attica General Hospital

Cardiology Clinic

Kifisiá, Greece

General Hospital Of Nea Ionia Konstantopouleio Patision

Cardiology Clinic

Néa Ionía, Greece

Sponsor: Win Medica Pharmaceutical S.A.

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.